US Stock MarketDetailed Quotes

INmune Bio (INMB)

Watchlist
  • 1.460
  • +0.070+5.04%
Close May 13 16:00 ET
  • 1.410
  • -0.050-3.42%
Post 18:13 ET
38.81MMarket Cap-0.90P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

INmune Bio (INMB) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
257.14%50K
0
0
0
257.14%50K
-90.97%14K
0
0
0
Operating revenue
--0
257.14%50K
--0
--0
--0
257.14%50K
-90.97%14K
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-41.62%5.81M
-27.50%30.92M
-42.18%5.47M
-39.50%7.43M
-18.33%8.06M
-9.75%9.96M
42.66%42.65M
12.61%9.47M
43.34%12.29M
52.78%9.87M
Selling and administrative expenses
-6.26%2.17M
8.19%10.26M
48.77%3.15M
14.74%2.55M
-19.88%2.25M
-0.94%2.32M
-1.45%9.48M
-11.92%2.11M
-14.19%2.22M
21.78%2.81M
-General and administrative expense
-6.26%2.17M
8.19%10.26M
48.77%3.15M
14.74%2.55M
-19.88%2.25M
-0.94%2.32M
-1.45%9.48M
-11.92%2.11M
-14.19%2.22M
21.78%2.81M
Research and development costs
-52.34%3.64M
-37.71%20.66M
-68.33%2.33M
-51.46%4.89M
-17.71%5.8M
-12.12%7.64M
63.60%33.17M
22.41%7.35M
68.20%10.07M
70.03%7.05M
Operating profit
41.32%-5.81M
27.60%-30.87M
42.18%-5.47M
39.50%-7.43M
18.33%-8.06M
10.09%-9.91M
-43.35%-42.64M
-12.98%-9.47M
-44.07%-12.29M
-53.88%-9.87M
Net non-operating interest income expense
Other net income (expense)
143.98%405K
-2,824.05%-15.06M
-15.66%210K
397.93%961K
-13,882.35%-16.4M
2,175.00%166K
307.12%553K
958.62%249K
651.43%193K
232.22%119K
Special income (charges)
----
---16.51M
--0
--0
---16.51M
----
--0
--0
--0
----
-Less:Impairment of capital assets
----
--16.51M
--0
--0
--16.51M
----
--0
--0
--0
----
Other non- operating income (expenses)
143.98%405K
162.21%1.45M
-15.66%210K
397.93%961K
-5.04%113K
2,175.00%166K
307.12%553K
958.62%249K
651.43%193K
232.22%119K
Income before tax
44.48%-5.41M
-9.15%-45.93M
42.89%-5.26M
46.48%-6.47M
-150.95%-24.46M
11.66%-9.74M
-40.24%-42.08M
-9.63%-9.22M
-41.22%-12.09M
-49.92%-9.75M
Income tax
Net income
44.48%-5.41M
-9.15%-45.93M
42.89%-5.26M
46.48%-6.47M
-150.95%-24.46M
11.66%-9.74M
-40.24%-42.08M
-9.63%-9.22M
-41.22%-12.09M
-49.92%-9.75M
Net income continuous Operations
44.48%-5.41M
-9.15%-45.93M
42.89%-5.26M
46.48%-6.47M
-150.95%-24.46M
11.66%-9.74M
-40.24%-42.08M
-9.63%-9.22M
-41.22%-12.09M
-49.92%-9.75M
Minority interest income
Net income attributable to the parent company
44.48%-5.41M
-9.15%-45.93M
42.89%-5.26M
46.48%-6.47M
-150.95%-24.46M
11.66%-9.74M
-40.24%-42.08M
-9.63%-9.22M
-41.22%-12.09M
-49.92%-9.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
44.48%-5.41M
-9.15%-45.93M
42.89%-5.26M
46.48%-6.47M
-150.95%-24.46M
11.66%-9.74M
-40.24%-42.08M
-9.63%-9.22M
-41.22%-12.09M
-49.92%-9.75M
Basic earnings per share
53.49%-0.2
11.85%-1.86
55.00%-0.18
60.00%-0.24
-110.00%-1.05
29.51%-0.43
-26.35%-2.11
14.89%-0.4
-25.00%-0.6
-38.89%-0.5
Diluted earnings per share
53.49%-0.2
11.85%-1.86
55.00%-0.18
60.00%-0.24
-110.00%-1.05
29.51%-0.43
-26.35%-2.11
14.89%-0.4
-25.00%-0.6
-38.89%-0.5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0257.14%50K000257.14%50K-90.97%14K000
Operating revenue --0257.14%50K--0--0--0257.14%50K-90.97%14K--0--0--0
Cost of revenue
Gross profit
Operating expense -41.62%5.81M-27.50%30.92M-42.18%5.47M-39.50%7.43M-18.33%8.06M-9.75%9.96M42.66%42.65M12.61%9.47M43.34%12.29M52.78%9.87M
Selling and administrative expenses -6.26%2.17M8.19%10.26M48.77%3.15M14.74%2.55M-19.88%2.25M-0.94%2.32M-1.45%9.48M-11.92%2.11M-14.19%2.22M21.78%2.81M
-General and administrative expense -6.26%2.17M8.19%10.26M48.77%3.15M14.74%2.55M-19.88%2.25M-0.94%2.32M-1.45%9.48M-11.92%2.11M-14.19%2.22M21.78%2.81M
Research and development costs -52.34%3.64M-37.71%20.66M-68.33%2.33M-51.46%4.89M-17.71%5.8M-12.12%7.64M63.60%33.17M22.41%7.35M68.20%10.07M70.03%7.05M
Operating profit 41.32%-5.81M27.60%-30.87M42.18%-5.47M39.50%-7.43M18.33%-8.06M10.09%-9.91M-43.35%-42.64M-12.98%-9.47M-44.07%-12.29M-53.88%-9.87M
Net non-operating interest income expense
Other net income (expense) 143.98%405K-2,824.05%-15.06M-15.66%210K397.93%961K-13,882.35%-16.4M2,175.00%166K307.12%553K958.62%249K651.43%193K232.22%119K
Special income (charges) -------16.51M--0--0---16.51M------0--0--0----
-Less:Impairment of capital assets ------16.51M--0--0--16.51M------0--0--0----
Other non- operating income (expenses) 143.98%405K162.21%1.45M-15.66%210K397.93%961K-5.04%113K2,175.00%166K307.12%553K958.62%249K651.43%193K232.22%119K
Income before tax 44.48%-5.41M-9.15%-45.93M42.89%-5.26M46.48%-6.47M-150.95%-24.46M11.66%-9.74M-40.24%-42.08M-9.63%-9.22M-41.22%-12.09M-49.92%-9.75M
Income tax
Net income 44.48%-5.41M-9.15%-45.93M42.89%-5.26M46.48%-6.47M-150.95%-24.46M11.66%-9.74M-40.24%-42.08M-9.63%-9.22M-41.22%-12.09M-49.92%-9.75M
Net income continuous Operations 44.48%-5.41M-9.15%-45.93M42.89%-5.26M46.48%-6.47M-150.95%-24.46M11.66%-9.74M-40.24%-42.08M-9.63%-9.22M-41.22%-12.09M-49.92%-9.75M
Minority interest income
Net income attributable to the parent company 44.48%-5.41M-9.15%-45.93M42.89%-5.26M46.48%-6.47M-150.95%-24.46M11.66%-9.74M-40.24%-42.08M-9.63%-9.22M-41.22%-12.09M-49.92%-9.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 44.48%-5.41M-9.15%-45.93M42.89%-5.26M46.48%-6.47M-150.95%-24.46M11.66%-9.74M-40.24%-42.08M-9.63%-9.22M-41.22%-12.09M-49.92%-9.75M
Basic earnings per share 53.49%-0.211.85%-1.8655.00%-0.1860.00%-0.24-110.00%-1.0529.51%-0.43-26.35%-2.1114.89%-0.4-25.00%-0.6-38.89%-0.5
Diluted earnings per share 53.49%-0.211.85%-1.8655.00%-0.1860.00%-0.24-110.00%-1.0529.51%-0.43-26.35%-2.1114.89%-0.4-25.00%-0.6-38.89%-0.5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.52%
Sample Name
Sample Code
 +18.03%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.87%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.63%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.98%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.76%
5
Hesai
HSAI
+7.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -